These findings are supported by our observations in human gastric cancer samples, in particular of the GS subtype, of a positive correlation between components of the IL-11/gp130/STAT3 signalling pathway and YAP1/TEAD1 (Table S1 and Fig S2). This evidence concerns the gene STAT3 and gastric cancer.